gi-hepatology
Glasgow Alcoholic Hepatitis Score
Predicts 28-day mortality in alcoholic hepatitis. Score ≥9 identifies patients likely to benefit from corticosteroids.
Score interpretation
Lower Risk 5–8
28-day survival ~87%. Lower risk of short-term mortality.
→ Supportive care; nutritional support; alcohol abstinence. Corticosteroids not indicated.
High Risk — Steroids Indicated 9–12
28-day survival ~46%. High short-term mortality.
→ Corticosteroids indicated (prednisolone 40 mg/day × 28 days); reassess at 7 days with Lille score
Interpretation bands for the Glasgow AH Score. Apply clinical judgement and local guidance.
References
- Forrest EH et al. Analysis of factors predictive of short-term mortality in alcoholic hepatitis. J Hepatol. 2005;43(2):279–285.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Drugs
- Methotrexate (Dermatology — Psoriasis) · Disease-Modifying Antirheumatic / Immunosuppressant
- Acetazolamide (Ménière's Disease) · Carbonic Anhydrase Inhibitor (Diuretic)
- Zinc acetate · Zinc salt (Wilson's disease)
- Sulfasalazine · Aminosalicylate / Disease-Modifying Antirheumatic Drug (DMARD)
- Entecavir · Antiviral — Hepatitis B (Nucleoside Analogue)
- Tenofovir (TDF/TAF) · Antiviral — Hepatitis B (Nucleotide Analogue)
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.